Wilfred de Vega

Wilfred Carlo de Vega, PhD, is a Business Development Specialist at Mitacs, Toronto, Canada. He completed his doctorate in the Department of Cell & Systems Biology at the University of Toronto, Toronto, Ontario, Canada under the supervision of Dr. Patrick McGowan.

Doctorate thesis

 * 2018, DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - De Vega's thesis research examined genome-wide epigenetic changes associated with ME/CFS and how these changes have downstream consequences on stress hormone sensitivity which could potentially relate to clinical subtypes based on symptom severity. His thesis work and ME/CFS research in the McGowan lab were funded by the Solve ME/CFS Initiative, Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), and the Falk Medical Research Foundation. (Abstract) (Full Text)

Publications related to ME/CFS

 * 2014, DNA Methylation Modifications Associated with Chronic Fatigue Syndrome (Full Text)
 * 2017, Editorial - The epigenetic landscape of myalgic encephalomyelitis/chronic fatigue syndrome: deciphering complex phenotypes (Full Text)
 * 2017, Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (Full Text)
 * 2018, Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome (Abstract)
 * 2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Abstract)

Talks and interviews

 * MillionsMissing Canada Interview of Wilfred de Vega

Online presence

 * PubMed
 * LinkedIn

Learn more

 * Will de Vega: Man of the Moment in ME Research in Canada! by Jill T for Health Rising
 * University of Toronto study offers hope sufferers chronic fatigue syndrome in U of T News